Valeritas Receives 510(k) Clearance for Insulin Delivery Device

Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that the U.S. Food and Drug Administration has cleared the company’s V-Go Disposable Insulin Delivery Device for use with Novo Nordisk’s NovoLog for the continuous subcutaneous delivery of insulin in preset basal rates and with on-demand bolus dosing for adult patients requiring insulin.
Fresh News